Literature DB >> 21329834

Assessment of myocardial fibrosis with cardiovascular magnetic resonance.

Nathan Mewton1, Chia Ying Liu, Pierre Croisille, David Bluemke, João A C Lima.   

Abstract

Diffuse interstitial or replacement myocardial fibrosis is a common feature of a broad variety of cardiomyopathies. Myocardial fibrosis leads to impaired cardiac diastolic and systolic function and is related to adverse cardiovascular events. Cardiovascular magnetic resonance (CMR) may uniquely characterize the extent of replacement fibrosis and may have prognostic value in various cardiomyopathies. Myocardial longitudinal relaxation time mapping is an emerging technique that could improve CMR's diagnostic accuracy, especially for interstitial diffuse myocardial fibrosis. As such, CMR could be integrated in the monitoring and therapeutic management of a large number of patients. This review summarizes the advantages and limitations of CMR for the assessment of myocardial fibrosis.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21329834      PMCID： PMC3081658          DOI： 10.1016/j.jacc.2010.11.013

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


  102 in total

Review 1.  The role of cardiovascular magnetic resonance imaging in heart failure.

Authors:  Theodoros D Karamitsos; Jane M Francis; Saul Myerson; Joseph B Selvanayagam; Stefan Neubauer
Journal:  J Am Coll Cardiol       Date:  2009-10-06       Impact factor: 24.094

2.  Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy.

Authors:  Simon Schalla; Sebastiaan C Bekkers; Robert Dennert; Robert J van Suylen; Johannes Waltenberger; Tim Leiner; Joachim Wildberger; Harry J Crijns; Stephane Heymans
Journal:  Eur J Heart Fail       Date:  2010-03       Impact factor: 15.534

3.  Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.

Authors:  Bethany A Austin; W H Wilson Tang; E Rene Rodriguez; Carmela Tan; Scott D Flamm; David O Taylor; Randall C Starling; Milind Y Desai
Journal:  JACC Cardiovasc Imaging       Date:  2009-12

4.  The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis.

Authors:  B Y C Cheong; R Muthupillai; M Nemeth; B Lambert; D Dees; S Huber; R Castriotta; S D Flamm
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2009-07       Impact factor: 0.670

5.  Detection of myocardial damage in patients with sarcoidosis.

Authors:  Manesh R Patel; Peter J Cawley; John F Heitner; Igor Klem; Michele A Parker; Wael A Jaroudi; Trip J Meine; James B White; Michael D Elliott; Han W Kim; Robert M Judd; Raymond J Kim
Journal:  Circulation       Date:  2009-11-02       Impact factor: 29.690

6.  Gender differences in survival in patients with severe left ventricular dysfunction despite similar extent of myocardial scar measured on cardiac magnetic resonance.

Authors:  Deborah H Kwon; Carmel M Halley; Zoran B Popovic; Thomas P Carrigan; Victoria Zysek; Randolph Setser; Paul Schoenhagen; Scott D Flamm; Randall C Starling; Milind Y Desai
Journal:  Eur J Heart Fail       Date:  2009-10       Impact factor: 15.534

7.  Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo.

Authors:  Antonella Moreo; Giuseppe Ambrosio; Benedetta De Chiara; Min Pu; Tam Tran; Francesco Mauri; Subha V Raman
Journal:  Circ Cardiovasc Imaging       Date:  2009-09-03       Impact factor: 7.792

8.  Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.

Authors:  Ronen Rubinshtein; James F Glockner; Steve R Ommen; Philip A Araoz; Michael J Ackerman; Paul Sorajja; J Martijn Bos; A Jamil Tajik; Uma S Valeti; Rick A Nishimura; Bernard J Gersh
Journal:  Circ Heart Fail       Date:  2009-10-22       Impact factor: 8.790

9.  Prognostic value of late gadolinium enhancement in hypertensive patients with known or suspected coronary artery disease.

Authors:  Rungroj Krittayaphong; Thananya Boonyasirinant; Vithaya Chaithiraphan; Adisak Maneesai; Pairash Saiviroonporn; Supaporn Nakyen; Prajak Thanapiboonpol; Ahthit Yindeengam; Suthipol Udompanturak
Journal:  Int J Cardiovasc Imaging       Date:  2010-01-05       Impact factor: 2.357

10.  Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity.

Authors:  Giovanni Donato Aquaro; Piergiorgio Masci; Francesco Formisano; Andrea Barison; Elisabetta Strata; Alessandro Pingitore; Vincenzo Positano; Paolo Spirito; Massimo Lombardi
Journal:  Am J Cardiol       Date:  2009-12-22       Impact factor: 2.778
View more
  306 in total

Review 1.  Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.

Authors:  Ljuba Bacharova; Martin Ugander
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-04       Impact factor: 1.468

2.  Relationship of left ventricular mass to coronary atherosclerosis and myocardial ischaemia: the CORE320 multicenter study.

Authors:  Satoru Kishi; Tiago A Magalhaes; Richard T George; Marc Dewey; Roger J Laham; Hiroyuki Niinuma; Lisa Aronson Friedman; Christopher Cox; Yutaka Tanami; Joanne D Schuijf; Andrea L Vavere; Kakuya Kitagawa; Marcus Y Chen; Cesar H Nomura; Jeffrey A Brinker; Frank J Rybicki; Marcelo F Di Carli; Armin Arbab-Zadeh; Joao A C Lima
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-11-02       Impact factor: 6.875

Review 3.  Cardiac remodeling at the population level--risk factors, screening, and outcomes.

Authors:  Ola Gjesdal; David A Bluemke; Joao A Lima
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

Review 4.  Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise?

Authors:  Thijs M H Eijsvogels; Antonio B Fernandez; Paul D Thompson
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

5.  Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy.

Authors:  Lu Fang; Andris H Ellims; Anna L Beale; Andrew J Taylor; Andrew Murphy; Anthony M Dart
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 6.  Heart failure in patients with normal coronary anatomy: diagnostic algorithm and disease pattern of various etiologies as defined by cardiac MRI.

Authors:  Ralf Wassmuth
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

Review 7.  Sex related differences in the pathogenesis of organ fibrosis.

Authors:  Alejandra Garate-Carrillo; Julisa Gonzalez; Guillermo Ceballos; Israel Ramirez-Sanchez; Francisco Villarreal
Journal:  Transl Res       Date:  2020-03-16       Impact factor: 7.012

8.  Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity.

Authors:  Dylan J Richards; Yang Li; Charles M Kerr; Jenny Yao; Gyda C Beeson; Robert C Coyle; Xun Chen; Jia Jia; Brooke Damon; Robert Wilson; E Starr Hazard; Gary Hardiman; Donald R Menick; Craig C Beeson; Hai Yao; Tong Ye; Ying Mei
Journal:  Nat Biomed Eng       Date:  2020-04-13       Impact factor: 25.671

9.  Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study.

Authors:  Jong-Chan Youn; Yoo Jin Hong; Hye-Jeong Lee; Kyunghwa Han; Chi Young Shim; Geu-Ru Hong; Young Joo Suh; Jin Hur; Young Jin Kim; Byoung Wook Choi; Seok-Min Kang
Journal:  Eur Radiol       Date:  2017-04-24       Impact factor: 5.315

10.  Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort: the Multi-Ethnic Study of Atherosclerosis (MESA) study.

Authors:  Sirisha Donekal; Bharath A Venkatesh; Yuan Chang Liu; Chia-Ying Liu; Kihei Yoneyama; Colin O Wu; Marcelo Nacif; Antoinette S Gomes; W Gregory Hundley; David A Bluemke; Joao A C Lima
Journal:  Circ Cardiovasc Imaging       Date:  2014-02-18       Impact factor: 7.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.